Literature DB >> 29265509

Prevalence, predictors and clinical impact of potentially inappropriate prescriptions in hospital-discharged older patients: A prospective study.

Mario Bo1, Valeria Quaranta1, Gianfranco Fonte1, Yolanda Falcone1, Giulia Carignano2, Giorgetta Cappa2.   

Abstract

AIM: Potentially inappropriate prescriptions (PIP) have been highly reported in older patients, but few studies have investigated their association with adverse clinical outcomes. The present study aimed to evaluate the prevalence and predictors of PIP in hospital-discharged older adults, and to explore the association of PIP with death and rehospitalization.
METHODS: We carried out a multicenter prospective cohort study on hospital-discharged patients aged ≥65 years. Each patient underwent a comprehensive geriatric assessment, and the prevalence of PIP was obtained by applying Beers Criteria 2015 to discharge documents. Telephone follow up was carried out at 6 months.
RESULTS: The prevalence of PIP was 63%, and was associated with psychiatric-behavioral disorders (OR 1.64), the number of daily taken medications (OR 1.08) and long-term care discharge (OR 1.91), whereas better functional performance was protective (OR 0.93). Neither the presence nor the number of PIP were associated with rehospitalization or mortality at 6 months. However, insulin sliding scale (OR 4.97) and use of drugs inappropriate in heart failure (OR 4.64) were associated with an increased risk of rehospitalization, whereas prescription of digoxin ≥0.125 mg/daily (OR 1.77) and antipsychotics (OR 1.65) were associated with a higher risk of mortality.
CONCLUSIONS: Among older hospital-discharged patients, we documented a high prevalence of PIP that was significantly associated with polytherapy, the presence of psychiatric-behavioral disorders and discharge to long-term care facilities. Although the presence and the number of PIP were not associated with adverse outcomes, some specific inappropriate prescriptions were associated with a higher risk of hospital readmission and death. Geriatr Gerontol Int 2018; 18: 561-568.
© 2017 Japan Geriatrics Society.

Entities:  

Keywords:  Beers criteria; drug-drug interaction; inappropriate prescriptions

Mesh:

Year:  2017        PMID: 29265509     DOI: 10.1111/ggi.13216

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  5 in total

1.  Prescription of proton pump inhibitors in older adults with complex polytherapy.

Authors:  Clara Cena; Sara Traina; Beatrice Parola; Mario Bo; Riccardo Fagiano; Carlotta Siviero
Journal:  Eur J Hosp Pharm       Date:  2019-03-16

2.  Potentially Inappropriate Medications, Drug-Drug Interactions, and Anticholinergic Burden in Elderly Hospitalized Patients: Does an Association Exist with Post-Discharge Health Outcomes?

Authors:  Antonio De Vincentis; Paolo Gallo; Panaiotis Finamore; Claudio Pedone; Luisa Costanzo; Luca Pasina; Laura Cortesi; Alessandro Nobili; Pier Mannuccio Mannucci; Raffaele Antonelli Incalzi
Journal:  Drugs Aging       Date:  2020-08       Impact factor: 3.923

3.  Barriers to effective prescribing in older adults: applying the theoretical domains framework in the ambulatory setting - a scoping review.

Authors:  Sabrina Lau; Penny Lun; Wendy Ang; Keng Teng Tan; Yew Yoong Ding
Journal:  BMC Geriatr       Date:  2020-11-09       Impact factor: 3.921

4.  Potentially inappropriate medications for the elderly: Incidence and impact on mortality in a cohort ten-year follow-up.

Authors:  Natacha Christina de Araújo; Erika Aparecida Silveira; Brenda Godoi Mota; João Paulo Neves Mota; Ana Elisa Bauer de Camargo Silva; Rafael Alves Guimarães; Valéria Pagotto
Journal:  PLoS One       Date:  2020-10-28       Impact factor: 3.240

Review 5.  Potentially inappropriate prescribing and its associations with health-related and system-related outcomes in hospitalised older adults: A systematic review and meta-analysis.

Authors:  Alemayehu B Mekonnen; Bernice Redley; Barbora de Courten; Elizabeth Manias
Journal:  Br J Clin Pharmacol       Date:  2021-05-18       Impact factor: 4.335

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.